Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

ETRA

Electra Therapeutics, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • ETRAElectra Therapeutics Inc.
    0Calm

    Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

    Signing up patientsPhase 2/3156 patientsMain results: Mar 2028

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 24 purchases

  • GORDON CARL LBoard member · Nov 5, 2026Bought 30,891 sharesabout $226 thousand ·
  • GORDON CARL LBoard member · Nov 5, 2026Bought 125,200 sharesabout $915 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 5, 2026Bought 30,891 sharesabout $226 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 5, 2026Bought 125,200 sharesabout $915 thousand ·
  • GORDON CARL LBoard member · Nov 4, 2026Bought 9,267 sharesabout $72 thousand ·
  • GORDON CARL LBoard member · Nov 4, 2026Bought 37,100 sharesabout $289 thousand ·
  • GORDON CARL LBoard member · Nov 4, 2026Bought 5,000 sharesabout $35 thousand ·
  • GORDON CARL LBoard member · Nov 4, 2026Bought 20,000 sharesabout $141 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 4, 2026Bought 9,267 sharesabout $72 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 4, 2026Bought 37,100 sharesabout $289 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 4, 2026Bought 5,000 sharesabout $35 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 4, 2026Bought 20,000 sharesabout $141 thousand ·
  • GORDON CARL LBoard member · Nov 3, 2026Bought 24,313 sharesabout $191 thousand ·
  • GORDON CARL LBoard member · Nov 3, 2026Bought 97,800 sharesabout $767 thousand ·
  • GORDON CARL LBoard member · Nov 3, 2026Bought 24,400 sharesabout $192 thousand ·
  • GORDON CARL LBoard member · Nov 3, 2026Bought 98,600 sharesabout $777 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 3, 2026Bought 24,313 sharesabout $191 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 3, 2026Bought 97,800 sharesabout $767 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 3, 2026Bought 24,400 sharesabout $192 thousand ·
  • ORBIMED ADVISORS LLCBoard member · Nov 3, 2026Bought 98,600 sharesabout $777 thousand ·
  • GORDON CARL LBoard member · Sep 21, 2026Bought 333,333 sharesabout $5.0 million ·
  • GORDON CARL LBoard member · Sep 21, 2026Bought 1,000,000 sharesabout $15.0 million ·
  • ORBIMED ADVISORS LLCBoard member · Sep 21, 2026Bought 333,333 sharesabout $5.0 million ·
  • ORBIMED ADVISORS LLCBoard member · Sep 21, 2026Bought 1,000,000 sharesabout $15.0 million ·

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Other newsNews report (8-K)Sep 21, 2026
  • Permission to sell new sharesPermission to sell new shares (S-1)Aug 28, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.